AORT
ARTIVION, INC.Company Information
- Company Name
- ARTIVION, INC.
- CIK
- CIK0000784199
- Category
- Large accelerated filer
- Ticker: Exchange
- AORT: NYSE
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- AORT
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-03-05
- Last sale
- 2026-09-10
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 476,219
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 45,043,266
- Shares outstanding
- 48,541,000
- Ownership
- 92.79%
Earnings Market Reaction
- Filing date
- 2026-08-07
- Price on filing date
- —
- 1-month reaction
- -1.29%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 77 | 56 | 65 | 73 | 53 | 38 | 53 | 56 | 55 | 51 | 59 | 53 | ||||||
| Accounts Receivable Net Current | 98 | 92 | 90 | 88 | 91 | 88 | 79 | 76 | 74 | 74 | 72 | 64 | ||||||
| Other Receivables Net Current | 13 | 14 | 14 | 9 | 10 | 8 | 6 | 2 | 5 | 2 | 2 | 4 | ||||||
| Inventory Net | 103 | 98 | 92 | 91 | 87 | 82 | 80 | 84 | 81 | 82 | 82 | 79 | ||||||
| Prepaid Expense And Other Assets Current | 27 | 45 | 43 | 22 | 25 | 20 | 19 | 19 | 20 | 17 | 16 | 17 | ||||||
| Assets Current | 371 | 358 | 358 | 337 | 319 | 287 | 290 | 288 | 285 | 277 | 281 | 267 | ||||||
| Goodwill | 350 | 252 | 254 | 254 | 254 | 245 | 241 | 249 | 244 | 245 | 247 | 243 | ||||||
| Finite Lived Intangible Assets Net | 149 | 120 | 124 | 126 | 129 | 128 | 128 | 135 | 135 | 138 | 143 | 143 | ||||||
| Operating Lease Right Of Use Asset | 37 | 35 | 35 | 39 | 40 | 39 | 40 | 41 | 42 | 42 | 44 | 43 | ||||||
| Property Plant And Equipment Net | 74 | 68 | 65 | 41 | 40 | 38 | 36 | 38 | 37 | 38 | 38 | 37 | ||||||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | - | - | - | - | - | - | - | - | - | - | 38 | - | ||||||
| Other Intangible Assets Net | 75 | 35 | 33 | 30 | 29 | 29 | 28 | 30 | 29 | 30 | 30 | 29 | ||||||
| Deferred Income Tax Assets Net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 4 | ||||||
| Other Assets Noncurrent | 15 | 16 | 15 | 29 | 27 | 25 | 24 | 21 | 14 | 13 | 9 | 8 | ||||||
| Assets | 1,072 | 883 | 885 | 858 | 838 | 791 | 789 | 803 | 790 | 784 | 792 | 775 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 21 | 18 | 16 | 16 | 19 | 12 | 18 | 11 | 12 | 10 | 13 | 11 | ||||||
| Employee Related Liabilities Current | 18 | 14 | 22 | 18 | 16 | 12 | 18 | 15 | 14 | 11 | 19 | 14 | ||||||
| Accrued Liabilities Current | 16 | 17 | 16 | 12 | 11 | 12 | 12 | 16 | 16 | 16 | 10 | 10 | ||||||
| Interest Payable Current | 7 | 4 | 5 | 6 | 6 | 7 | 8 | - | - | - | 2 | - | ||||||
| Taxes Payable Current | 6 | 7 | 7 | 2 | 3 | 2 | 3 | 4 | 2 | 2 | 4 | 9 | ||||||
| Business Combination Contingent Consideration Liability Current | 25 | 21 | 21 | 19 | - | - | 0 | - | - | - | - | - | ||||||
| Operating Lease Liability Current | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 5 | 3 | 3 | 3 | 4 | ||||||
| Finance Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | - | - | 1 | - | ||||||
| Other Liabilities Current | 7 | 3 | 5 | 4 | 3 | 1 | 1 | 1 | 2 | 2 | 2 | 4 | ||||||
| Long Term Debt Current | - | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 1 | 2 | ||||||
| Liabilities Current | 107 | 93 | 102 | 86 | 67 | 52 | 67 | 153 | 51 | 46 | 58 | 55 | ||||||
| Long Term Debt Noncurrent | 363 | 215 | 215 | 215 | 216 | 315 | 314 | 214 | 313 | 313 | 306 | 306 | ||||||
| Business Combination Contingent Consideration Liability Noncurrent | 72 | 41 | 40 | 37 | 53 | 50 | 53 | 52 | 48 | 46 | 64 | 62 | ||||||
| Operating Lease Liability Noncurrent | 36 | 34 | 34 | 38 | 39 | 39 | 40 | 41 | 42 | 43 | 44 | 43 | ||||||
| Deferred Income Tax Liabilities Net | 26 | 28 | 24 | 22 | 23 | 22 | 20 | 19 | 22 | 22 | 22 | 20 | ||||||
| Deferred Compensation Liability Classified Noncurrent | 11 | 10 | 9 | 9 | 9 | 8 | 8 | 8 | 7 | 7 | 7 | 6 | ||||||
| Finance Lease Liability Noncurrent | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
| Other Liabilities Noncurrent | 9 | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 8 | 7 | 8 | ||||||
| Liabilities | 626 | 433 | 437 | 419 | 418 | 497 | 513 | 498 | 494 | 489 | 511 | 503 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 536 | 526 | 517 | 509 | 497 | 389 | 377 | 373 | 368 | 363 | 356 | 351 | ||||||
| Retained Earnings Accumulated Deficit | -64 | -50 | -51 | -54 | -60 | -62 | -61 | -45 | -42 | -40 | -48 | -44 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -12 | -12 | -3 | -2 | -3 | -19 | -25 | -10 | -16 | -14 | -12 | -21 | ||||||
| Treasury Stock Common Value | -15 | -15 | -15 | -15 | -15 | -15 | -15 | -15 | -15 | -15 | -15 | -15 | ||||||
| Stockholders Equity | 446 | 450 | 448 | 439 | 420 | 294 | 276 | 305 | 295 | 295 | 282 | 272 | ||||||
| Liabilities And Stockholders Equity | 1,072 | 883 | 885 | 858 | 838 | 791 | 789 | 803 | 790 | 784 | 792 | 775 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | - | - | - | 0.01 | - | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | - | - | - | 5 | - | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | - | - | - | 0.01 | - | ||||||
| Common Stock Shares Authorized | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | ||||||
| Common Stock Shares Issued | 50 | 50 | 49 | 49 | 49 | 44 | 43 | 43 | 43 | 43 | 43 | 43 | ||||||
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | 43 | ||||||
| Treasury Stock Common Shares | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialARTIVION, INC. (AORT) — SEC Financial Statements & Analysis
ARTIVION, INC. (AORT) is a surgical & medical instruments & apparatus company, incorporated in DE. ARTIVION, INC. trades on NYSE as: AORT. ARTIVION, INC. (AORT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07. Based on that filing, ARTIVION, INC. carries a market cap of $1.09B, a P/E ratio of -344.62x, a P/B ratio of 2.45x, a P/S ratio of 2.31x, an enterprise value of $1.38B, and an EV/EBITDA multiple of 30.48x. On profitability, it posts a gross margin of 64.37%, an operating margin of 4.38%, a net margin of -0.67%, a Return on Equity (ROE) of -0.73%, a Return on Assets (ROA) of -0.33%, and a Return on Invested Capital (ROIC) of 0.00%. Per share, it reports EPS of $-0.07, diluted EPS of $-0.07, free cash flow per share of $-0.19, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 16.40% year-over-year, net income growth of -82.35% year-over-year, and EPS growth of -83.89% year-over-year. On the balance sheet, it maintains a current ratio of 3.47x, a quick ratio of 2.26x, working capital of $264.45M, a debt-to-equity ratio of 1.41x, a debt ratio of 0.58, an interest coverage ratio of 0.85x, free cash flow of $-9.16M (TTM), and net debt of $286.97M. Figures sourced from SEC EDGAR.
- Market Cap
- $1.09B
- P/E TTM
- -344.62x
- EPS TTM
- $-0.07
- P/B TTM
- 2.45x
- ROE TTM
- -0.73%
- ROA TTM
- -0.33%
- Debt To Equity
- 1.41x
- Free Cash Flow TTM
- $-9.16M
- Net Revenue TTM Growth 1Y
- 16.40%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is ARTIVION, INC. in?
ARTIVION, INC. (AORT) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does AORT trade on?
ARTIVION, INC. (AORT) trades on the NYSE.
Where is ARTIVION, INC. incorporated?
ARTIVION, INC. is incorporated in DE.
When was ARTIVION, INC. (AORT)'s most recent SEC filing?
ARTIVION, INC. (AORT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07.
What is AORT's market cap?
ARTIVION, INC. (AORT) has a market capitalization of $1.09B as of 2026-06-30.
What is AORT's EPS (earnings per share)?
ARTIVION, INC. (AORT)'s trailing twelve month EPS is $-0.07 as of 2026-06-30.
What is AORT's ROE (return on equity)?
ARTIVION, INC. (AORT)'s trailing twelve month Return on Equity (ROE) is -0.73% as of 2026-06-30.
What is AORT's ROA (return on assets)?
ARTIVION, INC. (AORT)'s trailing twelve month Return on Assets (ROA) is -0.33% as of 2026-06-30.
What is AORT's ROIC (return on invested capital)?
ARTIVION, INC. (AORT)'s trailing twelve month Return on Invested Capital (ROIC) is 0.00% as of 2026-06-30.
What is AORT's EV/EBITDA?
ARTIVION, INC. (AORT)'s trailing twelve month EV/EBITDA is 30.48x as of 2026-06-30.